You are the owner of this page.
Edit Page
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

ANI Pharma Inc (NQ: ANIP )

29.00 USD -0.79 (-2.65%)
Official Closing Price Updated: 4:00 PM EDT, Oct 19, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,900
Open 29.60
Bid (Size) 29.00 (2)
Ask (Size) 29.11 (3)
Prev. Close 29.79
Today's Range 28.89 - 30.20
52wk Range 25.23 - 80.87
Shares Outstanding 11,786,416
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ANI Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Compensation Committee of ANI’s Board of Directors granted a non-qualified inducement stock option to purchase... 
From Business Wire News Releases
ANI Pharmaceuticals Reports Second Quarter 2020 Results
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2020. 
From Business Wire News Releases

Performance

YTD
-51.72%
-51.72%
1 Month
+2.73%
+2.73%
3 Month
-1.29%
-1.29%
6 Month
-33.55%
-33.55%
1 Year
-61.78%
-61.78%

More News

Read More
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors
From Business Wire News Releases
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
From PR Newswire
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer
From Business Wire News Releases
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
From PR Newswire
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results
From Business Wire News Releases
ANI Pharmaceuticals Provides Update on Recent Regulatory Filing
From PR Newswire
ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO
From PR Newswire
Add Up The Parts: SPSM Could Be Worth $32
Tags ETFs
From ETF Channel
Look Under The Hood: EES Has 14% Upside
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.